27Mar

HORIBA Medical launches D-Dimer reagent for Yumizen G Haemostasis range

Horibalogo

Northampton, UK – 21 March 2019 – HORIBA UK Ltd, Medical announces the launch of a D-Dimer parameter for its Yumizen G haemostasis range of instruments. The new Yumizen G DDi 2 (D-Dimer) reagent kit offers a key measurement and reference exclusion test for the diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE). It can also be used for monitoring the progress and effectiveness of treatment of Disseminated Intravascular Coagulation (DIC).

HORIBA Medical’s new D-Dimer reagent kit is available for its full range of coagulation instruments which covers the needs of any laboratory. The dedicated haemostasis portfolio includes the fully automatic Yumizen G800, Yumizen G1500 and Yumizen G1550, as well as semi-automatic Yumizen G200 and Yumizen G400 analysers. Using antibody-coated latex particles and measured via the immuno-turbidimetric channels of these Yumizen G instruments, the new reagent kit delivers D-Dimer results consistency across the range.

The D-Dimer assay when used on very compact coagulation screening platforms such as the Yumizen G400DDi and Yumizen G200, which also have combined immuno-turbidimetric and chromogenic assay capabilities, is particularly ideal for small laboratories, hot labs and as backup. On these semi-automatic systems, the Yumizen G DDi 2 reagent kit offers an innovative combination of immuno-turbidimetric test capability and pre-calibrated ready-to-use reagent.

Offering a cost-efficient solution, the new assay minimises preparation time due to its ready-to-use liquid format. Furthermore, as the reagent is pre-calibrated it removes the need for a costly and time-consuming calibration step. Its high stability and optimised volume packaging also avoids wastage.

HORIBA Medical’s new D-Dimer test kit is fully compliant with Gold Standard performances, having a Negative Predictive Value of 99% and an absence of hook effect up to 25 µg FEU/ml. It also offers slope check and post dilution function on both fully automatic and semi-automatic systems with a cut-off value at 0.5 µg FEU/ml.

For more information on HORIBA UK Ltd. Medical and its products, including its new Yumizen GDDi 2 (D-Dimer) kit and Yumizen G haemostasis range of analysers, please visit: www.horiba.com/uk/medical.

Related

New Partnership for Biological Sample Transport Solutions

Specialist Laboratory and Diagnostics supply company Alpha Laboratories Ltd. (Eastleigh, UK) is deli...

Read More >

Cytox awarded new Innovate UK funding for Alzheimer’s disease testing

8 March 2018: Oxford & Manchester, UK. Cytox, an emerging precision medicine leader providing geneti...

Read More >

Strategic Partnership for New Bladder Cancer Diagnostic Test in the UK

Alpha Laboratories Ltd. (Eastleigh, UK) is delighted to have been appointed as the exclusive distrib...

Read More >

On World Cancer Day, Global Good and QuantuMDx Partner to Combat Cervical Cancer

Newcastle upon Tyne, UK – [February 2, 2017] – QuantuMDx Group announced an assay co-development a...

Read More >

OGT enhances customer experience with new Cytocell website

Oxford, UK – 7 March 2018. Oxford Gene Technology (OGT), The Molecular Genetics Company, has launch...

Read More >

Study confirms HORIBA POCT analyser enables earlier clinical decision-making in emergency paediatrics

Northampton, UK – 20th March 2018 – HORIBA UK Ltd, Medical announces that in a study recently unde...

Read More >